VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC) Meeting Abstract
| Authors: | Coleman, R. L.; Fleming, G. F.; Brady, M. F.; Swisher, E.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K.; Ben-Baruch, N.; Werner, T. L.; Oaknin, A.; Nam, J. H.; Leath, C. A. 3rd; Nicum, S.; Cella, D.; Sullivan, D. M.; Ansell, P. J.; Dinh, M.; Aghajanian, C.; Bookman, M. A. |
| Abstract Title: | VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | v895 |
| End Page: | v896 |
| Language: | English |
| ACCESSION: | WOS:000491295500127 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz394.054 |
| Notes: | Meeting Abstract: LBA3 -- Source: Wos |
